Designing numerical stimuli
|
|
0
|
2433
|
July 7, 2021
|
Default Using R package to implement Bayesian phase I/II dose-finding design for three outcomes
|
|
10
|
3479
|
June 10, 2021
|
Bootstrap and prior distribution method for self-controlled case series design
|
|
0
|
2129
|
June 9, 2021
|
Fully sequential Bayesian clinical trial design for in-hospital treatment of COVID-19
|
|
23
|
11331
|
June 7, 2021
|
Debunking myths: intention to treat , missing follow-up and imputation
|
|
6
|
3571
|
March 15, 2021
|
Sample size requirements for a proportional odds model
|
|
7
|
6020
|
March 15, 2021
|
Devising a database
|
|
7
|
4990
|
February 23, 2021
|
Value stream mapping - numbers needed
|
|
0
|
2754
|
February 8, 2021
|
Power Analysis for 3 Groups and 3 Measures
|
|
1
|
3417
|
February 7, 2021
|
DAGs for Bayesian hierarchical models?
|
|
4
|
6984
|
January 8, 2021
|
Sample size estimation
|
|
6
|
5178
|
November 14, 2020
|
RCT trials for COVID study vaccines
|
|
0
|
3088
|
October 24, 2020
|
"Open label, double-masked trial"
|
|
0
|
3340
|
October 13, 2020
|
Bayesian solution for study designs
|
|
0
|
3086
|
September 24, 2020
|
Factorial design - dropping factors and conditions
|
|
1
|
2314
|
September 1, 2020
|
Re-starting a Bayesian group sequential design trial after stopping it
|
|
4
|
2896
|
August 11, 2020
|
Stratification, block-randomization, etc
|
|
6
|
5559
|
August 4, 2020
|
Multiplicity in AIM-NIVO trial, uncontrolled by statistical discipline
|
|
0
|
2667
|
June 12, 2020
|
Seeking advice on Ethics and Efficiency of testing safety in a curative setting?
|
|
4
|
3334
|
May 31, 2020
|
When is censoring too high?
|
|
11
|
15621
|
May 28, 2020
|
Random vs. stratified sampling in estimating a varying treatment effect
|
|
0
|
2218
|
May 14, 2020
|
Self controlled case series
|
|
1
|
2980
|
May 6, 2020
|
COVID-19 Research Methods Resources
|
|
10
|
11234
|
May 4, 2020
|
Sample size calculation for intraclass correlation coefficient (ICC)
|
|
0
|
4221
|
May 1, 2020
|
Are hospital based retrospective cohort studies subject to Berkson's Bias?
|
|
1
|
2197
|
April 22, 2020
|
Illness Severity among Non-COVID patients
|
|
11
|
8295
|
April 19, 2020
|
Does Bayesian analysis render the 'primary endpoint' as irrelevant as multiplicity?
|
|
8
|
4275
|
April 10, 2020
|
Power calculations for cluster-RCT in hospital infection control (PPE for Covid19)
|
|
6
|
5117
|
April 1, 2020
|
Type I error in a specific design of 2-parallel group study
|
|
3
|
3583
|
March 11, 2020
|
Comparing continuous outcome in case-control-style design
|
|
2
|
2859
|
March 6, 2020
|